Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease
Publication
, Conference
Boelens, J-J; Chiesa, R; Duncan, C; Jones, SA; Kapoor, N; Kuehl, J-S; Lindemans, CA; Prasad, VK; Sevin, C; Shamir, E; Chin, W; McNeil, E; Orchard, PJ
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
March 1, 2020
Duke Scholars
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2020
Volume
26
Issue
3
Start / End Page
S211 / S211
Location
Orlando, FL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Boelens, J.-J., Chiesa, R., Duncan, C., Jones, S. A., Kapoor, N., Kuehl, J.-S., … Orchard, P. J. (2020). Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 26, pp. S211–S211). Orlando, FL: ELSEVIER SCIENCE INC.
Boelens, Jaap-Jan, Robert Chiesa, Chrstine Duncan, Simon A. Jones, Neena Kapoor, Joern-Sven Kuehl, Caroline A. Lindemans, et al. “Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 26:S211–S211. ELSEVIER SCIENCE INC, 2020.
Boelens J-J, Chiesa R, Duncan C, Jones SA, Kapoor N, Kuehl J-S, et al. Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S211–S211.
Boelens, Jaap-Jan, et al. “Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 26, no. 3, ELSEVIER SCIENCE INC, 2020, pp. S211–S211.
Boelens J-J, Chiesa R, Duncan C, Jones SA, Kapoor N, Kuehl J-S, Lindemans CA, Prasad VK, Sevin C, Shamir E, Chin W, McNeil E, Orchard PJ. Transplant- and Disease-Related Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Patients with Cerebral Adrenoleukodystrophy Vary By Donor Cell Source, Conditioning Regimen, and Stage of Cerebral Disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. ELSEVIER SCIENCE INC; 2020. p. S211–S211.
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
March 1, 2020
Volume
26
Issue
3
Start / End Page
S211 / S211
Location
Orlando, FL
Publisher
ELSEVIER SCIENCE INC
Conference Name
Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences